ARCHIVES

A Biostatistics Paper Alleges Potential Harm To Patients In Two Duke Clinical Studies

This article is from The Cancer Letter archive.

Vol. 35 No. 36 | October 2, 2009

Download PDF Visit The Full Archive

Related Articles

Study: Rencarex Treatment Efficacy Increases With CAIX Antigen Density in Tumor Tissue

March 29, 2013

In Brief: ACR to Move From Chicago To Washington D.C. Area; Hanks Astro President, Phillips President Elect

December 16, 1983

NIH Not Proactive, Healy Tells NCAB ‘Beset’ By Issues

February 12, 1993

FDA News: FDA Taking Comments on “First Generic” ANDA Process

November 21, 2014

Racial Differences In Survival Increase According To Stage

August 31, 2007

Phase III Trial Would Give Clearer Picture Of C225 Role.

February 15, 2002